Brokerages Set CVS Health Corporation (NYSE:CVS) Target Price at $94.91

Shares of CVS Health Corporation (NYSE:CVS) have been assigned an average rating of “Moderate Buy” from the twenty-three analysts that are presently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and nineteen have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $94.9091.

A number of research analysts have recently issued reports on the stock. Jefferies Financial Group raised their price target on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Evercore lifted their target price on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. TD Cowen upped their target price on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Robert W. Baird raised their price target on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Finally, Mizuho upped their price objective on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th.

Institutional Investors Weigh In On CVS Health

Large investors have recently made changes to their positions in the company. National Pension Service raised its position in shares of CVS Health by 3.1% during the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock worth $301,532,000 after purchasing an additional 119,189 shares during the period. AE Wealth Management LLC raised its holdings in CVS Health by 6.2% during the 3rd quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after buying an additional 14,983 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after buying an additional 22,653 shares during the period. Alpha Omega Wealth Management LLC increased its position in shares of CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock worth $11,301,000 after acquiring an additional 16,418 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its holdings in shares of CVS Health by 186.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock valued at $30,568,000 after acquiring an additional 258,050 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 2.6%

Shares of CVS Health stock opened at $76.12 on Monday. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The business has a 50-day moving average price of $78.35 and a 200 day moving average price of $77.02. CVS Health has a fifty-two week low of $58.35 and a fifty-two week high of $85.15. The firm has a market cap of $96.84 billion, a P/E ratio of 55.16, a P/E/G ratio of 0.77 and a beta of 0.50.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the previous year, the business earned $1.19 EPS. The business’s quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, sell-side analysts forecast that CVS Health will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were given a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s dividend payout ratio (DPR) is currently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.